Nitazene Opioids and Heart Risks
Author Information
Author(s): Hancox Jules C., Wang Yibo, Copeland Caroline S., Zhang Henggui, Harmer Stephen C., Henderson Graeme
Primary Institution: University of Bristol
Hypothesis
Do nitazene opioids inhibit the hERG potassium channel, posing cardiac risks?
Conclusion
Nitazene opioids are predicted to inhibit the hERG channel, indicating a potential risk for cardiac arrhythmias.
Supporting Evidence
- All nitazenes were predicted to inhibit hERG with low μM IC50 values.
- Predictions indicate a potential for proarrhythmic hERG block by nitazene opioids.
- Previous studies have linked methadone and other opioids to QT prolongation.
Takeaway
Nitazene opioids might mess with your heart by blocking a key channel, which could lead to serious heart problems.
Methodology
Machine-learning tools were used to evaluate the interaction of five nitazene compounds with the hERG potassium channel.
Potential Biases
Potential bias due to reliance on computational predictions without in vitro validation.
Limitations
The study focuses solely on hERG and does not assess interactions with other cardiac channels.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website